Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A
Links shared publicly online about this topic.
- 958total visits
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A
View full resource at medicalnewstoday.com
Tags: Hemophilia, Drug, FDA, Pfizer
Most Recently Shared on August 10, 2010 at 1:00 pm By:
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A http://mnt.to/3H9R #regulatory
Also Shared By:
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A - QualityPoint Technologies
qualitypointtech.net — “Pfizer Inc.has announced that the U.S. Food and Drug Administration (FDA) has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is a recombinant factor VIII product indicated for both the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with he” View full resource at qualitypointtech.net
Most Recently Shared on August 10, 2010 at 11:57 am By:
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A: Pfizer I... http://bit.ly/bK0qIB
Advertisement
MNT Blood
@mnt_blood
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A http://mnt.to/3H9R
1 year ago...